| Dr Michael David Jameson, MD | |
|
1132 S Bowen Rd, Arlington, TX 76013-2204 | |
| (817) 265-9700 | |
| (817) 277-4164 |
| Full Name | Dr Michael David Jameson |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 39 Years |
| Location | 1132 S Bowen Rd, Arlington, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306895347 | NPI | - | NPPES |
| 89K852 | Other | TX | BLUE CROSS BLUE SHIELD |
| 007 | Other | TRICARE | |
| 390001182 | Other | RAILROAD MEDICARE | |
| 047890101 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | HO492 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ameri-tech Kidney Center-arlington Llc | Arlington, TX | Dialysis facility |
| Texas Health Arlington Memorial Hospital | Arlington, TX | Hospital |
| Medical City Arlington | Arlington, TX | Hospital |
| Methodist Mansfield Medical Center | Mansfield, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Texas Nephrology Associates Pa | 7214910850 | 5 |
News Archive
Lower awareness of COVID-19, poorer health and economic conditions could reduce the effectiveness of lockdowns in developing countries, according to researchers from The University of Western Australia.
Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review of the Biologics License Application (BLA) for the investigational agent ZALTRAP (aflibercept) concentrate for solution for infusion in combination with the irinotecan-fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer (mCRC) previously treated with an oxaliplatin-containing regimen.
University of Washington researcher Jessie Fudge, MD received the Dr. Harry L. Galanty Young Investigator's Award for excellence in sports medicine research at the 21st American Medical Society for Sports Medicine Annual Meeting in Atlanta, Ga. on April 24, 2012.
Scientific insights that expand on the teachings of Mendel, Watson and Crick, and underpinnings of the Human Genome Project are moving drug companies along the path to development of new medicines based on deeper insights into how factors other than the genetic code influence health and disease. That's the topic of the cover story in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), the world's largest scientific society.
› Verified 4 days ago
| Entity Name | North Texas Nephrology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629107404 PECOS PAC ID: 7214910850 Enrollment ID: O20040612000428 |
News Archive
Lower awareness of COVID-19, poorer health and economic conditions could reduce the effectiveness of lockdowns in developing countries, according to researchers from The University of Western Australia.
Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review of the Biologics License Application (BLA) for the investigational agent ZALTRAP (aflibercept) concentrate for solution for infusion in combination with the irinotecan-fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer (mCRC) previously treated with an oxaliplatin-containing regimen.
University of Washington researcher Jessie Fudge, MD received the Dr. Harry L. Galanty Young Investigator's Award for excellence in sports medicine research at the 21st American Medical Society for Sports Medicine Annual Meeting in Atlanta, Ga. on April 24, 2012.
Scientific insights that expand on the teachings of Mendel, Watson and Crick, and underpinnings of the Human Genome Project are moving drug companies along the path to development of new medicines based on deeper insights into how factors other than the genetic code influence health and disease. That's the topic of the cover story in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), the world's largest scientific society.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael David Jameson, MD 8600 Meadowbrook Dr, Fort Worth, TX 76120-4612 Ph: (817) 265-9700 | Dr Michael David Jameson, MD 1132 S Bowen Rd, Arlington, TX 76013-2204 Ph: (817) 265-9700 |
News Archive
Lower awareness of COVID-19, poorer health and economic conditions could reduce the effectiveness of lockdowns in developing countries, according to researchers from The University of Western Australia.
Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review of the Biologics License Application (BLA) for the investigational agent ZALTRAP (aflibercept) concentrate for solution for infusion in combination with the irinotecan-fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer (mCRC) previously treated with an oxaliplatin-containing regimen.
University of Washington researcher Jessie Fudge, MD received the Dr. Harry L. Galanty Young Investigator's Award for excellence in sports medicine research at the 21st American Medical Society for Sports Medicine Annual Meeting in Atlanta, Ga. on April 24, 2012.
Scientific insights that expand on the teachings of Mendel, Watson and Crick, and underpinnings of the Human Genome Project are moving drug companies along the path to development of new medicines based on deeper insights into how factors other than the genetic code influence health and disease. That's the topic of the cover story in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), the world's largest scientific society.
› Verified 4 days ago
Dr. Waldo P Bracy Jr., M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1001 N Waldrop Dr, Ste. 509, Arlington, TX 76012 Phone: 817-394-4300 Fax: 817-394-0200 | |
Thang D Le, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 800 W Randol Mill Rd Ste 2300, Arlington, TX 76012 Phone: 866-202-1032 Fax: 817-548-6649 | |
Dr. Hujefa Yusuf Vora, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3150 Matlock Rd, Suite 403, Arlington, TX 76015 Phone: 817-784-0052 Fax: 817-375-5800 | |
Dr. Raza Askari, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 515 W Mayfield Rd Ste 210, Arlington, TX 76014 Phone: 817-375-5847 | |
Thuc Quyen Thi Nguyen, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 515 W Mayfield Rd, Suite 210, Arlington, TX 76014 Phone: 817-417-4027 Fax: 817-417-4043 | |
Dr. Bienvenido Gatmaitan Gatmaitan, Nephrology Medicare: Not Enrolled in Medicare Practice Location: 621 Matlock Centre Cir, Arlington, TX 76015 Phone: 817-860-6062 Fax: 817-795-6652 | |
Bernard A Mcgowen, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1217 Florida Dr, Suite 121, Arlington, TX 76015 Phone: 817-419-9155 Fax: 817-419-9412 |